Convention | Molefuture is attending the 2024 BIO International Convention!

The BIO International Convention is a key event in the biotechnology industry, showcasing the latest trends and innovative technologies. On June 3-6, 2024(EDT), the BIO International Convention (BIO2024), will be held in San Diego Convention Center, USA.

We are excited to announce that Molefuture will attend the 2024 BIO International Convention! Dr. Xiang Liu, CEO of Molefuture, and Dr. Dongliang Song,Vice President of Yeasen, will lead company's technical teams in a collaborative exploration with global biotechnology industry leaders at the event. Together, We will delve into the realm of biotechnology, discussing cutting-edge innovations and emerging industry trends. Moreover, we are pursuing business collaboration prospects that offer expansive avenues for growth and development. Molefuture will showcase its cutting-edge enzyme evolution technology and services, along with its latest advancements in T7 RNA polymerase. We eagerly anticipate our gathering to partake in this momentous occasion !

About US

Molefuture Biotechnology (Shanghai) Co., Ltd., a subsidiary of Yeasen Biotechnology (Shanghai) Co., Ltd., specializes in tailored enzyme modification solutions driven by cutting-edge enzyme evolution technologies. These solutions cater to diverse application needs in areas such as in vitro diagnostics, biopharmaceuticals, synthetic biology, medical aesthetics, pharmaceutical intermediates, and beyond.

For More Information

Tel： +86 136-5175-3995

Email：Support@molefuture.com